Page last updated: 2024-10-24

caffeine and Synovioma

caffeine has been researched along with Synovioma in 2 studies

Research Excerpts

ExcerptRelevanceReference
" We recently reported that recombinant methioninase (rMETase) inhibited SS growth in a patient-derived orthotopic xenograft (PDOX) mouse model and was more effective when administered in combination with the first-line drug doxorubicin (DOX)."1.48Oral Recombinant Methioninase Combined with Caffeine and Doxorubicin Induced Regression of a Doxorubicin-resistant Synovial Sarcoma in a PDOX Mouse Model. ( Chawla, SP; Eilber, FC; Han, Q; Hayashi, K; Higuchi, T; Hoffman, RM; Igarashi, K; Kawaguchi, K; Kimura, H; Miwa, S; Miyake, K; Oshiro, H; Razmjooei, S; Singh, AS; Singh, SR; Sugisawa, N; Tan, Y; Tsuchiya, H; Yamamoto, N; Zhang, Z, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Higuchi, T1
Kawaguchi, K1
Miyake, K1
Han, Q1
Tan, Y1
Oshiro, H1
Sugisawa, N1
Zhang, Z1
Razmjooei, S1
Yamamoto, N1
Hayashi, K1
Kimura, H1
Miwa, S1
Igarashi, K1
Chawla, SP1
Singh, AS1
Eilber, FC1
Singh, SR1
Tsuchiya, H2
Hoffman, RM1
Morinaga, T1
Taki, J1
Sumiya, H1
Matsui, O1
Tomita, K1

Other Studies

2 other studies available for caffeine and Synovioma

ArticleYear
Oral Recombinant Methioninase Combined with Caffeine and Doxorubicin Induced Regression of a Doxorubicin-resistant Synovial Sarcoma in a PDOX Mouse Model.
    Anticancer research, 2018, Volume: 38, Issue:10

    Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Caffeine; Carbon-Sulfur Lyases; Central

2018
Effect of myocutaneous inflammatory changes caused by intra-arterial chemotherapy on the outcome of patients who undergo limb-saving surgery.
    Cancer, 2001, Jun-15, Volume: 91, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Caffeine; Child; Combined Modality Therapy

2001